Kidney-Targeted Nanoparticle Delivery of Formoterol Mitigates Diabetic Kidney Disease without Adverse Cardiac Effects Article

Vallorz, Ernest L, Cleveland, Kristan, Scholpa, Natalie E et al. (2026). Kidney-Targeted Nanoparticle Delivery of Formoterol Mitigates Diabetic Kidney Disease without Adverse Cardiac Effects . ACS Pharmacology and Translational Science, 9(6), 1426-1438. 10.1021/acsptsci.6c00009

cited authors

  • Vallorz, Ernest L; Cleveland, Kristan; Scholpa, Natalie E; Mansour, Heidi M; Schnellmann, Jennifer; Schnellmann, Rick G

authors

publication date

  • June 12, 2026

published in

keywords

  • BETA(2)-ADRENOCEPTOR AGONISTS
  • Chemistry, Medicinal
  • DOXORUBICIN
  • ENCAPSULATION
  • INJURY
  • Life Sciences & Biomedicine
  • MITOCHONDRIAL
  • MOLECULAR-MECHANISMS
  • NEPHROPATHY
  • Pharmacology & Pharmacy
  • RELEASE
  • RENAL PROXIMAL TUBULE
  • SALMETEROL
  • Science & Technology
  • diabetic kidneydisease
  • formoterol
  • nanoparticles
  • renal failure

Digital Object Identifier (DOI)

publisher

  • AMER CHEMICAL SOC

start page

  • 1426

end page

  • 1438

volume

  • 9

issue

  • 6